Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06674759

Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis

Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis: a Randomized, Double-blind, Placebo-controlled Clinical Study

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Conditions Knee Osteoarthritis (Knee OA)

Interventions Tongren-Dahuoluo Bolus Tongren-Dahuoluo Bolus Placebo

Updated 1 time since 2024 Last updated: Nov 3, 2024 Started: Jan 10, 2025 Primary completion: Jun 30, 2025 Completion: Dec 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06674759, this PHASE4 trial focuses on Knee Osteoarthritis (Knee OA) and remains actively recruiting participants. Sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — PHASE4 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Data source: Guang'anmen Hospital of China Academy of Chinese Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.